Philip Morris to Sell Inhalation Drug Delivery Company Vectura
Molex has agreed to acquire Vectura, an inhalation drug delivery company, from Philip Morris, with plans to expand its capabilities in inhaled therapeutics.
Molex has agreed to acquire Vectura, an inhalation drug delivery company, from Philip Morris, with plans to expand its capabilities in inhaled therapeutics.
Molex has agreed to acquire Vectura, an inhalation drug delivery company, from Philip Morris, with plans to expand its capabilities in inhaled therapeutics.
Read MoreHealthcare organizations are concerned respiratory medication delivery technology will now be used to more effectively deliver tobacco and nicotine.
Read MoreA class-action lawsuit was recently brought by 250,000 West Virginia smokers against five tobacco companies.
Read MorePhilip Morris Co recently released a company-funded report in the Czech Republic promoting the fact that one of the positive effects of smoking is the early deaths of smokers.
Read More